MA29759B1 - 1h-imidazopyridines a substituant hydroxy et procedes - Google Patents

1h-imidazopyridines a substituant hydroxy et procedes

Info

Publication number
MA29759B1
MA29759B1 MA30694A MA30694A MA29759B1 MA 29759 B1 MA29759 B1 MA 29759B1 MA 30694 A MA30694 A MA 30694A MA 30694 A MA30694 A MA 30694A MA 29759 B1 MA29759 B1 MA 29759B1
Authority
MA
Morocco
Prior art keywords
substituted
methods
imidazopyridines
compounds
hydroxy
Prior art date
Application number
MA30694A
Other languages
English (en)
Inventor
Joseph F Dellaria Jr
William H Moser
Matthew R Radmer
George W Griesgraber
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MA29759B1 publication Critical patent/MA29759B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

1H-imidazopyridines à substituant hydroxy et procédés Des 1H-imidazo[4,5-c]pyridine-4-amines à substituant hydroxy, avec un substituant hydroxy en position 2, des compositions pharmaceutiques contenant ces composés, des procédés pour la préparation des composés, des intermédiaires, et des méthodes d'utilisation de ces composés comme immunomodulateurs, pour induire la biosynthèse de cytokines chez des animaux et dans le traitement de maladies comprenant des maladies virales et maladies néoplasiques, sont décrits.
MA30694A 2005-09-02 2008-02-29 1h-imidazopyridines a substituant hydroxy et procedes MA29759B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71370405P 2005-09-02 2005-09-02

Publications (1)

Publication Number Publication Date
MA29759B1 true MA29759B1 (fr) 2008-09-01

Family

ID=37561219

Family Applications (1)

Application Number Title Priority Date Filing Date
MA30694A MA29759B1 (fr) 2005-09-02 2008-02-29 1h-imidazopyridines a substituant hydroxy et procedes

Country Status (20)

Country Link
US (2) US20100152230A1 (fr)
EP (1) EP1924581A1 (fr)
JP (1) JP4584335B2 (fr)
KR (1) KR20080031496A (fr)
CN (1) CN101253173A (fr)
AU (1) AU2006287157A1 (fr)
BR (1) BRPI0615250A2 (fr)
CA (1) CA2620933A1 (fr)
CR (1) CR9781A (fr)
EA (1) EA200800396A1 (fr)
EC (1) ECSP088225A (fr)
IL (1) IL189262A0 (fr)
MA (1) MA29759B1 (fr)
MX (1) MX2008002414A (fr)
NO (1) NO20081393L (fr)
RS (1) RS20080128A (fr)
SV (1) SV2009002832A (fr)
TN (1) TNSN08099A1 (fr)
WO (1) WO2007028129A1 (fr)
ZA (1) ZA200801645B (fr)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265351A1 (en) 2003-04-10 2004-12-30 Miller Richard L. Methods and compositions for enhancing immune response
WO2005018556A2 (fr) 2003-08-12 2005-03-03 3M Innovative Properties Company Composes contenant une structure imidazo a substitution hydroxylamine
ES2406730T3 (es) 2003-08-27 2013-06-07 3M Innovative Properties Company Imidazoquinolinas sustituidas con ariloxi y arilalquilenoxi
AU2004270201A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for CD5+ B cell lymphoma
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
CA2540598C (fr) 2003-10-03 2013-09-24 3M Innovative Properties Company Pyrazolopyridines et analogues de celles-ci
CA2540541C (fr) 2003-10-03 2012-03-27 3M Innovative Properties Company Imidazoquinolines a substitution alcoxy
WO2005048945A2 (fr) 2003-11-14 2005-06-02 3M Innovative Properties Company Composes d'un anneau d'imidazo substitue par hydroxylamine
EP1685129A4 (fr) 2003-11-14 2008-10-22 3M Innovative Properties Co Composes d'un anneau d'imidazo substitues par oxime
JP4891088B2 (ja) 2003-11-25 2012-03-07 スリーエム イノベイティブ プロパティズ カンパニー 置換されたイミダゾ環系および方法
JP2007517035A (ja) 2003-12-29 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
CA2551399A1 (fr) 2003-12-30 2005-07-21 3M Innovative Properties Company Sulfonamides d'imidazoquinolinyle, d'imidazopyridinyle et d'imidazonaphtyridinyle
CA2559863A1 (fr) 2004-03-24 2005-10-13 3M Innovative Properties Company Imidazopyridines, imidazoquinolines, et imidazonaphthyridines a substitution amide
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
US8541438B2 (en) 2004-06-18 2013-09-24 3M Innovative Properties Company Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
AU2005326708C1 (en) 2004-12-30 2012-08-30 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
AU2005322898B2 (en) 2004-12-30 2011-11-24 3M Innovative Properties Company Chiral fused (1,2)imidazo(4,5-c) ring compounds
CA2597092A1 (fr) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Formulations des gel aqueux contenant des modificateurs de reponse immunitaire
AU2006338521A1 (en) 2005-02-09 2007-10-11 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted thiazolo(4,5-c) ring compounds and methods
US20080318998A1 (en) 2005-02-09 2008-12-25 Coley Pharmaceutical Group, Inc. Alkyloxy Substituted Thiazoloquinolines and Thiazolonaphthyridines
WO2006086634A2 (fr) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Composes cycliques imidazo[4,5-c] substitues par oxime et hydroxylamine et procedes associes
US8658666B2 (en) 2005-02-11 2014-02-25 3M Innovative Properties Company Substituted imidazoquinolines and imidazonaphthyridines
JP2008538203A (ja) 2005-02-23 2008-10-16 コーリー ファーマシューティカル グループ，インコーポレイテッド インターフェロンの生合成を優先的に誘導する方法
EP1851224A2 (fr) 2005-02-23 2007-11-07 3M Innovative Properties Company Imidazoquinolines a substitution hydroxyalkyle
AU2006216798A1 (en) 2005-02-23 2006-08-31 Coley Pharmaceutical Group, Inc. Hydroxyalkyl substituted imidazoquinoline compounds and methods
CA2602590A1 (fr) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Composes cycliques 1-pyrazolo[3,4-c] substitues comme modulateurs de la biosynthese de cytokine destines au traitement d'infections virales et de maladies neoplastiques
EP1869043A2 (fr) 2005-04-01 2007-12-26 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines et analogues associes
JP2009507856A (ja) 2005-09-09 2009-02-26 コーリー ファーマシューティカル グループ，インコーポレイテッド Ｎ−｛２−［４−アミノ−２−（エトキシメチル）−１Ｈ−イミダゾ［４，５−ｃ］キノリン−１−イル］−１，１−ジメチルエチル｝メタンスルホンアミドのアミドおよびカルバマート誘導体ならびに方法
ZA200803029B (en) 2005-09-09 2009-02-25 Coley Pharm Group Inc Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods
JP5247458B2 (ja) 2005-11-04 2013-07-24 スリーエム・イノベイティブ・プロパティーズ・カンパニー ヒドロキシ及びアルコキシ置換１ｈ−イミダゾキノリン及び方法
MX2008010611A (es) 2006-02-17 2008-11-12 Pfizer Ltd Derivados de 3-desazapurina como moduladores de receptores similares a toll.
US8951528B2 (en) 2006-02-22 2015-02-10 3M Innovative Properties Company Immune response modifier conjugates
WO2007106854A2 (fr) 2006-03-15 2007-09-20 Coley Pharmaceutical Group, Inc. 1h-imidazonaphthyridines hydroxy et alcoxy substituées, et procédés associés
WO2008008432A2 (fr) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Composés à cycle [1,2] imidazo [4,5-c] fusionné chiral substitué et procédés correspondants
WO2008030511A2 (fr) 2006-09-06 2008-03-13 Coley Pharmaceuticial Group, Inc. 3, 4, 6, 7-tétrahydro-5h-1, 2a, 4a, 8-tétraazacyclopenta[cd]phénalènes substitués
US20080149123A1 (en) 2006-12-22 2008-06-26 Mckay William D Particulate material dispensing hairbrush with combination bristles
DE602008003764D1 (de) 2007-02-19 2011-01-13 Glaxosmithkline Llc Purinderivate als immunmodulatoren
EP1997805A1 (fr) * 2007-06-01 2008-12-03 Commissariat à l'Energie Atomique Compositions à activité antiparasite, applications associées au traitement des maladies infectieuses causées par des apicomplexans
CA2707030A1 (fr) * 2007-08-03 2009-02-12 Pfizer Limited Imidazopyridinones
LT2320905T (lt) 2008-08-11 2017-09-11 Glaxosmithkline Llc Naujieji adenino dariniai
UA103195C2 (uk) 2008-08-11 2013-09-25 Глаксосмитклайн Ллк Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань
US8802684B2 (en) 2008-08-11 2014-08-12 Glaxosmithkline Llc Adenine derivatives
US8575181B2 (en) 2008-08-11 2013-11-05 Glaxosmithkline Llc Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
EA021377B9 (ru) 2008-12-09 2015-09-30 Джилид Сайэнс, Инк. Модуляторы толл-подобных рецепторов
CA2772071A1 (fr) 2009-08-28 2011-03-03 Array Biopharma Inc. Composes inhibiteurs de raf et leurs procedes d'utilisation
SI2491035T1 (sl) * 2009-10-22 2017-10-30 Gilead Sciences, Inc. Derivati purina ali deazapurina uporabni za zdravljenje (med drugimi) virusnih okužb
US8575340B2 (en) 2010-02-10 2013-11-05 Glaxosmithkline Llc Purine derivatives and their pharmaceutical uses
HUE033901T2 (en) 2010-08-17 2018-01-29 3M Innovative Properties Co Formulations and formulations for lipidized immune response modifying compounds and related processes
JP6415979B2 (ja) 2011-06-03 2018-10-31 スリーエム イノベイティブ プロパティズ カンパニー ヒドラジノ１ｈ−イミダゾキノリン−４−アミン及びこれから調製された複合体
CA2838158C (fr) 2011-06-03 2019-07-16 3M Innovative Properties Company Lieurs heterobifonctionnels comportant de segments de polyethylene glycol et conjugues modificateurs de reponse immunitaire obtenus a partir de ceux-ci
RU2631482C2 (ru) 2011-07-22 2017-09-22 ГЛАКСОСМИТКЛАЙН ЭлЭлСи Композиция
CN103450198B (zh) * 2012-05-29 2015-07-08 首都医科大学 咪唑并吡啶并咪唑-3-取代乙酸苄酯、其合成、抗肿瘤活性及应用
WO2014031815A1 (fr) 2012-08-24 2014-02-27 Glaxosmithkline Llc Composés pyrazolopyrimidine
KR20150085081A (ko) 2012-11-20 2015-07-22 글락소스미스클라인 엘엘씨 신규 화합물
WO2014081645A1 (fr) 2012-11-20 2014-05-30 Glaxosmithkline Llc Nouveaux composés
EP2922550B1 (fr) 2012-11-20 2017-04-19 Glaxosmithkline LLC Nouveaux composés
UY36298A (es) 2014-09-16 2016-04-29 Gilead Science Inc Formas sólidas de un modulador del receptor tipo toll
JP7197244B2 (ja) 2017-12-20 2022-12-27 スリーエム イノベイティブ プロパティズ カンパニー 免疫応答調節剤として使用するための分岐鎖連結基を有するアミド置換イミダゾ［４，５－ｃ］キノリン化合物
WO2019209811A1 (fr) 2018-04-24 2019-10-31 Bristol-Myers Squibb Company Agonistes macrocycliques du récepteur 7 de type toll (tlr7)
US11554120B2 (en) 2018-08-03 2023-01-17 Bristol-Myers Squibb Company 1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor
US20230144824A1 (en) 2020-01-27 2023-05-11 Bristol-Myers Squibb Company 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS
KR20220132591A (ko) 2020-01-27 2022-09-30 브리스톨-마이어스 스큅 컴퍼니 톨-유사 수용체 7 (TLR7) 효능제로서의 1H-피라졸로[4,3-d]피리미딘 화합물
EP4097103A1 (fr) 2020-01-27 2022-12-07 Bristol-Myers Squibb Company Composés 1h-pyrazolo[4,3-d]pyrimidine utiles en tant qu'agonistes du récepteur de type toll 7 (tlr7)
CN115210236A (zh) 2020-01-27 2022-10-18 百时美施贵宝公司 作为Toll样受体7(TLR7)激动剂的1H-吡唑并[4,3-d]嘧啶化合物
EP4097105A1 (fr) 2020-01-27 2022-12-07 Bristol-Myers Squibb Company Composés 1h-pyrazolo[4,3-d]pyrimidine utiles en tant qu'agonistes du récepteur de type toll 7 (tlr7)
KR20220132594A (ko) 2020-01-27 2022-09-30 브리스톨-마이어스 스큅 컴퍼니 톨-유사 수용체 7 (TLR7) 효능제로서의 1H-피라졸로[4,3-d]피리미딘 화합물
JP2023512206A (ja) 2020-01-27 2023-03-24 ブリストル－マイヤーズ スクイブ カンパニー トール様受容体７（ＴＬＲ７）アゴニストとしての１Ｈ－ピラゾロ［４，３－ｄ］ピリミジン化合物
EP4097107A1 (fr) 2020-01-27 2022-12-07 Bristol-Myers Squibb Company Composés 1-pyrazolo[4,3-d]pyrimidine substitués en c3 utiles en tant qu'agonistes du récepteur de type toll 7 (tlr7)
KR20220132601A (ko) 2020-01-27 2022-09-30 브리스톨-마이어스 스큅 컴퍼니 톨-유사 수용체 7 (TLR7) 효능제로서의 1H-피라졸로[4,3-d]피리미딘 화합물
CN117466808B (zh) * 2023-12-27 2024-03-12 烟台新药创制山东省实验室 一种6-烷基-2,4-二羟基吡啶类衍生物的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09500128A (ja) * 1993-07-15 1997-01-07 ミネソタ マイニング アンド マニュファクチャリング カンパニー イミダゾ〔４，５−ｃ〕ピリジン−４−アミン
WO1998001448A1 (fr) * 1996-07-03 1998-01-15 Japan Energy Corporation Nouveaux derives de purine
KR100892614B1 (ko) * 2001-04-17 2009-04-09 다이닛본 스미토모 세이야꾸 가부시끼가이샤 신규 아데닌 유도체
EP1389618B1 (fr) * 2001-04-27 2011-06-15 Eisai R&D Management Co., Ltd. Pyrazolo 1,5-a pyridines et medicaments les contenant
AU2003237386A1 (en) * 2002-06-07 2003-12-22 3M Innovative Properties Company Ether substituted imidazopyridines
TWI325865B (en) * 2003-02-27 2010-06-11 Palau Pharma Sa Pyrazolopyridine derivatives
US7517887B2 (en) * 2003-04-09 2009-04-14 General Atomics Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
JP2005089334A (ja) * 2003-09-12 2005-04-07 Sumitomo Pharmaceut Co Ltd ８−ヒドロキシアデニン化合物
CN1997642B (zh) * 2003-09-22 2012-06-13 詹森药业有限公司 7-氨基亚烷基-杂环喹诺酮类和萘啶酮类
FR2860514A1 (fr) * 2003-10-03 2005-04-08 Sanofi Synthelabo Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
EP1685129A4 (fr) * 2003-11-14 2008-10-22 3M Innovative Properties Co Composes d'un anneau d'imidazo substitues par oxime
JP4891088B2 (ja) * 2003-11-25 2012-03-07 スリーエム イノベイティブ プロパティズ カンパニー 置換されたイミダゾ環系および方法
TW200616604A (en) * 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
MX2008010611A (es) * 2006-02-17 2008-11-12 Pfizer Ltd Derivados de 3-desazapurina como moduladores de receptores similares a toll.

Also Published As

Publication number Publication date
TNSN08099A1 (fr) 2009-07-14
EP1924581A1 (fr) 2008-05-28
IL189262A0 (en) 2008-06-05
CR9781A (es) 2008-03-26
RS20080128A (en) 2009-05-06
CN101253173A (zh) 2008-08-27
KR20080031496A (ko) 2008-04-08
JP4584335B2 (ja) 2010-11-17
ZA200801645B (en) 2010-08-25
WO2007028129A1 (fr) 2007-03-08
EA200800396A1 (ru) 2008-08-29
SV2009002832A (es) 2009-02-19
ECSP088225A (es) 2008-03-26
AU2006287157A1 (en) 2007-03-08
BRPI0615250A2 (pt) 2011-05-10
JP2009507036A (ja) 2009-02-19
US20100152230A1 (en) 2010-06-17
MX2008002414A (es) 2008-03-27
NO20081393L (no) 2008-05-28
US20120035209A1 (en) 2012-02-09
CA2620933A1 (fr) 2007-03-08

Similar Documents

Publication Publication Date Title
MA29759B1 (fr) 1h-imidazopyridines a substituant hydroxy et procedes
WO2008030511A3 (fr) 3, 4, 6, 7-tétrahydro-5h-1, 2a, 4a, 8-tétraazacyclopenta[cd]phénalènes substitués
MY161812A (en) Substituted imidazo ring systems and methods
WO2005079195A3 (fr) Pyrazolopyridines et analogues de celles-ci
MA32070B1 (fr) Dérivés hétérocycliques réunis par fusion et procédés d'utilisation associés
MA47447A (fr) 2-hétéroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides pour le traitement du cancer
BRPI0414856A (pt) imidazoquinolinas alcóxi-substituìdas
MA40290A1 (fr) Agents immunorégulateurs
MY148480A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2006091568A3 (fr) Imidazonaphthyridines a substitution hydroxyalkyle
MA27569A1 (fr) Derives de pyrrolo-pyrazole substitues servant d'inhibiteurs de kinases
MA34308B1 (fr) Triazolopyridines substituées
TW200505458A (en) 1-amino 1h-imidazoquinolines
MA27347A1 (fr) Inhibiteurs de protease du vih, compositions les contenant, leurs utilisations pharmaceutiques et matieres pour leur synthese
MA31764B1 (fr) Composés et compositions en tant que modulateurs de l'activité de gpr119
MA29932B1 (fr) Inhibiteurs de la proteine d'activation de la 5-lipoxygenase (flap)
BRPI0413998A (pt) imidazoquinolinas arilóxi e arilalquilenóxi substituìdas
MA31881B1 (fr) Dérivés de n-(arylamino)arylsulfonamide comprenant des polymorphes en tant qu'inhibiteurs de mek ainsi que compositions, procédés d'utilisation et procédés de préparation de ceux-ci
WO2007106854A3 (fr) 1h-imidazonaphthyridines hydroxy et alcoxy substituées, et procédés associés
MA30352B1 (fr) Pyridine [3,4-b] pyrazinones
WO2007056112A3 (fr) 1h-imidazoquinolines substituees par hydroxy et alcoxy et procedes correspondants
TNSN07476A1 (fr) Derives de n-(pyridine -2- yl) - sulfonamide
MA30821B1 (fr) Derives de pyrazoline utiles comme antagonistes des recepteurs de mineralocorticoïdes
MA30089B1 (fr) (arylsulfonyl)-pyrasolopiperidines
MA31857B1 (fr) N-phenyl-pyrrolidinylmethylpyrrolidine-amides substitues et utilisation therapeutique de ceux -ci